HARRISBURG – A measure is being reintroduced aimed at capping out-of-pocket insulin prices at $100 per month for Pennsylvanians. The out-of-pocket costs for insulin have increased dramatically during the last 20 years, threatening to price some people out of the medicine they need for a chronic, but treatable disease. Some have been forced to choose between medication and basic needs. House Bill 460 sets a mandatory price cap on the monthly cost of insulin for patients at $100 a month and calls on the state attorney general to investigate the choices made by pharmaceutical companies that have caused patient out-of-pocket costs to continue rising. The bill is before the state House Insurance Committee.